TC
IDXX icon

Truvestments Capital’s Idexx Laboratories IDXX Stock Holding History

Truvestments Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Sell
7
-7
-50% -$3.93K ﹤0.01% 944
2026
Q1 		$7.87K Sell
14
-4
-22% -$2.56K ﹤0.01% 803
2025
Q4 		$12.2K Hold
18
– – ﹤0.01% 670
2025
Q3 		$11.5K Sell
18
-12
-40% -$7.28K ﹤0.01% 694
2025
Q2 		$16.1K Hold
30
– – ﹤0.01% 576
2025
Q1 		$12.6K Sell
30
-3
-9% -$1.3K ﹤0.01% 621
2024
Q4 		$13.6K Buy
33
+13
+65% +$5.7K ﹤0.01% 552
2024
Q3 		$10.1K Buy
+20
New +$9.72K ﹤0.01% 579

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Truvestments Capital's IDXX Position: Q2 2026 in Review

Truvestments Capital reduced its Idexx Laboratories (IDXX) stake by 50% in Q2 2026, selling an estimated $3.93K and leaving 7 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #944.

Truvestments Capital first reported a position in IDXX in Q3 2024 and has held it in 8 quarters since. The position peaked at $16.1K in Q2 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Truvestments Capital held 7 shares of Idexx Laboratories worth $3.69K as of Q2 2026.
  • Truvestments Capital sold 7 Idexx Laboratories shares in Q2 2026, an estimated $3.93K.
  • Idexx Laboratories made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #944 holding.
  • Truvestments Capital first reported a position in Idexx Laboratories in Q3 2024 and has held it in 8 quarters since.
  • Truvestments Capital's Idexx Laboratories position peaked at $16.1K in Q2 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.